The company would manufacture Biopharmaceuticals in the plant coming up at Shapoorji Pallonji Biotech Park, Turkapally, 35 km from Hyderabad city, Andhra Pradesh, India. The company is supported by renowned Scientists and Technocrats in the field of Biotechnology.
The cost of the project is estimated at Rs. 6756.42 lakhs. The project is financed by equity share capital of Rs. 2308 lakhs which includes Core-promoters’ contribution to the extent of Rs. 808 lakhs and 1500 lakhs from Public Issue; the company has taken necessary steps to obtain the Term loan of Rs. 4448.42 lakhs from Financial Institutions.